Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV

INTRODUCTION: Cotrimoxazole (CTX) is recommended as prophylaxis against Pneumocystis jiroveci pneumonia, malaria and other serious bacterial infections in HIV‐infected patients. Despite its in vitro activity against Mycobacterium tuberculosis, the effects of CTX preventive therapy on tuberculosis (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ku, Stephane Wen‐Wei, Jiamsakul, Awachana, Joshi, Kedar, Pasayan, Mark Kristoffer Ungos, Widhani, Alvina, Chaiwarith, Romanee, Kiertiburanakul, Sasisopin, Avihingsanon, Anchalee, Ly, Penh Sun, Kumarasamy, Nagalingeswaran, Do, Cuong D, Merati, Tuti P, Nguyen, Kinh Van, Kamarulzaman, Adeeba, Zhang, Fujie, Lee, Man Po, Choi, Jun Yong, Tanuma, Junko, Khusuwan, Suwimon, Sim, Benedict Lim Heng, Ng, Oon Tek, Ratanasuwan, Winai, Ross, Jeremy, Wong, Wing‐Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439318/
https://www.ncbi.nlm.nih.gov/pubmed/30924281
http://dx.doi.org/10.1002/jia2.25264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439318/
https://www.ncbi.nlm.nih.gov/pubmed/30924281
http://dx.doi.org/10.1002/jia2.25264

Ejemplares similares